Compare Amphastar Pharmaceuticals Inc (AMPH) vs ON Holding AG (ONON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs ON Holding AG — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while ON Holding AG trades at $31.2 (market cap $12.93B). The key difference: ON Holding AG is far larger — about 15× Amphastar Pharmaceuticals Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals.
| AMPH | ONON | |
|---|---|---|
Market Cap | $863.95M | $12.93B |
Sector | Health | Technology |
52-Week High | $30.81 | $50.63 |
52-Week Low | $16.87 | $31.88 |
Enterprise Value | $1.26B | $12.25B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
ONON trades at $37.55, up 0.56% with bullish technical signals supported by moving averages. The company demonstrates strong fundamental performance with Q1 2026 EPS beating expectations at $0.47 vs. $0.34 expected, maintaining a streak of earnings surprises. Revenue growth to $3.01B in 2025 and expanding net margins to 8.02% reflect operational strength amid positive analyst sentiment.
The outlook remains positive with 77% analyst buy ratings and $52.57 consensus price target suggesting 40% upside potential. Key risks include premium valuation metrics (P/E 41.8, P/S 6.5) and tariff exposure, but strong DTC growth and margin expansion support the bullish case for growth investors seeking athletic footwear exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About ON Holding AG
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →
